NEXT PHARMA SOURCING SAS Immunoglobulin Import Data from India (DGFT 2022–2026)

Q: Who are the top buyers of Immunoglobulin from India and how much does NEXT PHARMA SOURCING SAS import?

India exports Immunoglobulin to 570 buyers globally worth $10.7M. NEXT PHARMA SOURCING SAS imports $850.0K (0.9% market share) with 17 shipments from COLOMBIA.

Q: What is the average order value for NEXT PHARMA SOURCING SAS's Immunoglobulin imports?

NEXT PHARMA SOURCING SAS's average Immunoglobulin order value is $50.0K per consignment, based on 17 shipments totaling $850.0K.

Q: Who supplies Immunoglobulin to NEXT PHARMA SOURCING SAS?

NEXT PHARMA SOURCING SAS sources Immunoglobulin from 1 verified supplier: RELIANCE LIFE SCIENCES PRIVATE LIMITED ($850.0K, 100.0%). Based on 17 customs records.

Q: How does NEXT PHARMA SOURCING SAS compare to other Immunoglobulin importers?

NEXT PHARMA SOURCING SAS ranks #7 among 570 Immunoglobulin importers from India with 0.9% market share and 17 shipments.

Q: Who are the top Immunoglobulin importers from India?

Top Immunoglobulin importers: AMBICA INTERNATIONAL CORPORATION ($2.5M), SIFA AERIEN ($1.1M), SEAN DOMINICAN SRL ($1.0M), STATE PHARMACEUTICALS CORPORATION ($850.0K), NEXT PHARMA SOURCING SAS ($800.0K).

Suresh Sormare

Immunoglobulin

India Pharmaceutical Trade Intelligence

$180.0M197 Suppliers119 CountriesHS 30021290

ExportsIndia → SRI LANKA15.5%India → UNITED ARAB13.7%

ImportsUNITED STATES → India$48.2B FRANCE → India$25.3B

#1 Supplier: RELIANCE LIFE #1 Buyer: STATE PHARMACEUTICALS

NEXT PHARMA SOURCING SAS — Immunoglobulin Importer #7 | $850.0K Trade Value | TransData Nexus | TransData Nexus

NEXT PHARMA SOURCING SAS — Immunoglobulin Importer Profile

Pharmaceutical Importer · #7 buyer for Immunoglobulin · $850.0K import value · 17 shipments · COLOMBIA · DGFT Verified

NEXT PHARMA SOURCING SAS is the #7 importer of Immunoglobulin from India with $850.0K in import value and 17 verified shipments. NEXT PHARMA SOURCING SAS holds a 0.9% market share in Immunoglobulin imports based in COLOMBIA. The company sources from 1 verified supplier across 6 formulations shipped to 1 country.

NEXT PHARMA SOURCING SAS — Immunoglobulin Import Profile: Suppliers, Formulations & Sources

NEXT PHARMA SOURCING SAS — Immunoglobulin import analysis from Indian Customs (DGFT) data.

Who Actually Supplies Immunoglobulin to NEXT PHARMA SOURCING SAS?

Verified from 17 customs shipment records

Supplier	Value	Shipments	% Share
RELIANCE LIFE SCIENCES PRIVATE LIMITED	$850.0K	17	100.0%

NEXT PHARMA SOURCING SAS sources Immunoglobulin from 1 verified Indian supplier based on 17 customs records. The primary supplier is RELIANCE LIFE SCIENCES PRIVATE LIMITED accounting for 100.0% of imports.

How Does NEXT PHARMA SOURCING SAS Compare to Nearest Immunoglobulin Importers?

Buyers ranked immediately above and below #7 by import value

#	Buyer

Where Does NEXT PHARMA SOURCING SAS Import Immunoglobulin To?

Destination countries from 17 verified shipments

Country	Value	Shipments	Share
COLOMBIA	$850.0K	17	100.0%

NEXT PHARMA SOURCING SAS imports Immunoglobulin to 1 country. The primary destination is COLOMBIA receiving 100.0% of shipments worth $850.0K.

What Immunoglobulin Formulations Does NEXT PHARMA SOURCING SAS Import?

Formulation	Value	Shipments
HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVENOUS ADMINISTRATION B.P.5% SOLUTION 100MLIMMUNOREL 5% 100ML	$200.0K	4
Immunorel 5% 100ml Human Normal Immunoglobulin for Intravenous Administration B.P., 5% Solution 100ml	$200.0K	4
HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVENOUS ADMINISTRATION B.P.5% SOLUTION 100ML(IMMUNOREL 5% 100ML)	$150.0K	3
HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVEN	$100.0K	2
HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVENOUS ADMINISTRATION B.P.5% SOLUTION 100ML(IMMUNOREL 5% 100ML)VLS	$100.0K	2
Immunorel 5 100ml Human Normal Immunoglobulin for Intravenous Administration B P 5 Solution 100ml	$100.0K	2

NEXT PHARMA SOURCING SAS imports 6 distinct Immunoglobulin formulations from India. The top formulation is HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVENOUS ADMINISTRATION B with 4 shipments worth $200.0K.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Immunoglobulin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
2.Buyer Identification: NEXT PHARMA SOURCING SAS matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
4.Market Share: Calculated as NEXT PHARMA SOURCING SAS's capped import value divided by total capped export value for Immunoglobulin across all Indian exporters.
5.Verified Records: This page is backed by 17 individual customs records matching NEXT PHARMA SOURCING SAS importing Immunoglobulin, covering 6 formulations from 1 verified supplier.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 119+ countries, 570+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Immunoglobulin

Immunoglobulin

NEXT PHARMA SOURCING SAS — Immunoglobulin Importer Profile

NEXT PHARMA SOURCING SAS — Immunoglobulin Import Profile: Suppliers, Formulations & Sources

Who Actually Supplies Immunoglobulin to NEXT PHARMA SOURCING SAS?

How Does NEXT PHARMA SOURCING SAS Compare to Nearest Immunoglobulin Importers?

Where Does NEXT PHARMA SOURCING SAS Import Immunoglobulin To?

What Immunoglobulin Formulations Does NEXT PHARMA SOURCING SAS Import?

Who Are the Top Buyers of Immunoglobulin from India and How Much Does NEXT PHARMA SOURCING SAS Import?

What Is the Average Order Value for NEXT PHARMA SOURCING SAS's Immunoglobulin Imports?

Who Supplies Immunoglobulin to NEXT PHARMA SOURCING SAS?

How Does NEXT PHARMA SOURCING SAS Compare to Other Immunoglobulin Importers?

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Immunoglobulin Import Data for NEXT PHARMA SOURCING SAS

NEXT PHARMA SOURCING SAS × Immunoglobulin

Related Analysis

Need Detailed Import Data?

Data Source

12	SEAN DOMINICAN SRL	DOMINICAN REPUBLIC	$1.0M	20	$50.0K
1	STATE PHARMACEUTICALS CORPORATION	SRI LANKA	$850.0K	17	$50.0K
7	NEXT PHARMA SOURCING SAS ★	COLOMBIA	$800.0K	16	$50.0K
5	DROGUERIA MK LAB S.A.C	PERU	$750.0K	15	$50.0K
4	LIBRA CHILE S.A	CHILE	$700.0K	14	$50.0K